Immunopotentiators in Modern Vaccines 2017
DOI: 10.1016/b978-0-12-804019-5.00010-4
|View full text |Cite
|
Sign up to set email alerts
|

Advax Adjuvant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…The sol-gel transition points after such interactions have been studied in the literature using the photon transmission technique [ 62 ] and are shown to increase gel formation, decrease solubility and significantly increase yield-point shear stress. Similarly, inulin also exhibited increased yield-point shear stress due to its six-turn helical configuration of the alpha-inulin polysaccharide in aqueous solution, which is affected by the aggregation of cations to the helix in a manner very similar to iota-carrageenan [ 63 , 64 , 65 ]. Although inulin has relatively low viscosity, the significant increase in viscosity under simulated digestion is not ideal for gastroparesis patients.…”
Section: Discussionmentioning
confidence: 99%
“…The sol-gel transition points after such interactions have been studied in the literature using the photon transmission technique [ 62 ] and are shown to increase gel formation, decrease solubility and significantly increase yield-point shear stress. Similarly, inulin also exhibited increased yield-point shear stress due to its six-turn helical configuration of the alpha-inulin polysaccharide in aqueous solution, which is affected by the aggregation of cations to the helix in a manner very similar to iota-carrageenan [ 63 , 64 , 65 ]. Although inulin has relatively low viscosity, the significant increase in viscosity under simulated digestion is not ideal for gastroparesis patients.…”
Section: Discussionmentioning
confidence: 99%
“…Data will be separately analyzed on adult (18 to 54 years of age) and elderly (55-75 years of age) healthy subjects enrolled in the study. In another study, the S protein has been administered with the Advax adjuvant (n. NCT04453852), a potent and safe immunopotentiator composed of delta inulin [103].…”
Section: Microbiotamentioning
confidence: 99%
“…A myriad of alternative adjuvants has been developed either with different chemical compositions (e.g. Freund's adjuvant, squalene, liposomes, MF59, lipids, cell exosomes or bacteria wall, etc), [18][19][20][21][22][23][24][25][26][27] or structurally different Al-based adjuvants, 15,28 but only a few have reached approval for human use as many exhibit either unacceptable side effects, insufficient immune responses, stability issues or difficulties in scaling-up. [29][30][31][32] Alternatively, the lack of cellular response in traditional Al-adjuvants can be compensated by the addition of immune orienteers (oligonucleotides, 33 imidazoquinoline, 34 TLR7 agonists 35 ).…”
Section: Introductionmentioning
confidence: 99%